NL293572A - - Google Patents

Info

Publication number
NL293572A
NL293572A NL293572DA NL293572A NL 293572 A NL293572 A NL 293572A NL 293572D A NL293572D A NL 293572DA NL 293572 A NL293572 A NL 293572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL293572A publication Critical patent/NL293572A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL293572D 1962-06-07 NL293572A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US200649A US3206470A (en) 1962-06-07 1962-06-07 Novel pyrrolo[1, 2-alpha]indoles

Publications (1)

Publication Number Publication Date
NL293572A true NL293572A (cg-RX-API-DMAC10.html)

Family

ID=22742594

Family Applications (1)

Application Number Title Priority Date Filing Date
NL293572D NL293572A (cg-RX-API-DMAC10.html) 1962-06-07

Country Status (8)

Country Link
US (1) US3206470A (cg-RX-API-DMAC10.html)
AT (1) AT250951B (cg-RX-API-DMAC10.html)
BE (1) BE633281A (cg-RX-API-DMAC10.html)
BR (1) BR6349521D0 (cg-RX-API-DMAC10.html)
DE (1) DE1445422A1 (cg-RX-API-DMAC10.html)
ES (1) ES288785A1 (cg-RX-API-DMAC10.html)
GB (1) GB1033253A (cg-RX-API-DMAC10.html)
NL (1) NL293572A (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4134894A (en) * 1978-05-04 1979-01-16 Warner-Lambert Company Pyrrolo[1,2-a]indole compounds
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
EP1515716A2 (en) 2002-04-03 2005-03-23 Astrazeneca AB Indole derivatives having anti-angiogenetic activity
NZ590474A (en) 2008-07-23 2012-10-26 Arena Pharm Inc SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
JP5726737B2 (ja) 2008-08-27 2015-06-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 自己免疫障害および免疫性障害の治療において有用なs1p1受容体のアゴニストとしての置換三環式酸誘導体
EP4148045A1 (en) 2010-01-27 2023-03-15 Arena Pharmaceuticals, Inc. Intermediate compounds for the preparation of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b] indol-3-yl)acetic acid and salts thereof
WO2011109471A1 (en) * 2010-03-03 2011-09-09 Arena Pharmaceuticals, Inc. Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
EP4445956A3 (en) 2015-01-06 2024-12-04 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
PL3310760T3 (pl) 2015-06-22 2023-03-06 Arena Pharmaceuticals, Inc. Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1
AU2018222747A1 (en) 2017-02-16 2019-09-05 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
CA3102136A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor
EP3847158A1 (en) 2018-09-06 2021-07-14 Arena Pharmaceuticals, Inc. Compounds useful in the treatment of autoimmune and inflammatory disorders
CN110878099B (zh) * 2019-11-25 2021-11-30 五邑大学 一种吡咯[1,2,α]吲哚生物碱衍生物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707187A (en) * 1952-07-14 1955-04-26 Upjohn Co Chemical process

Also Published As

Publication number Publication date
DE1445422A1 (de) 1969-04-10
ES288785A1 (es) 1963-11-16
BR6349521D0 (pt) 1973-07-03
BE633281A (fr) 1963-12-05
US3206470A (en) 1965-09-14
AT250951B (de) 1966-12-12
GB1033253A (en) 1966-06-22

Similar Documents

Publication Publication Date Title
BE616548R (cg-RX-API-DMAC10.html)
BE616909A (cg-RX-API-DMAC10.html)
BE633991A (cg-RX-API-DMAC10.html)
BE380301A (cg-RX-API-DMAC10.html)
BE489310A (cg-RX-API-DMAC10.html)
BE538252A (cg-RX-API-DMAC10.html)
BE538831A (cg-RX-API-DMAC10.html)
BE541929A (cg-RX-API-DMAC10.html)
BE553896A (cg-RX-API-DMAC10.html)
BE559145A (cg-RX-API-DMAC10.html)
BE586180A (cg-RX-API-DMAC10.html)
BE592434A (cg-RX-API-DMAC10.html)
BE599783A (cg-RX-API-DMAC10.html)
BE604335A (cg-RX-API-DMAC10.html)
BE608197A (cg-RX-API-DMAC10.html)
BE609543A (cg-RX-API-DMAC10.html)
BE612190A (cg-RX-API-DMAC10.html)
BE612311A (cg-RX-API-DMAC10.html)
BE612464A (cg-RX-API-DMAC10.html)
BE612847A (cg-RX-API-DMAC10.html)
BE612926A (cg-RX-API-DMAC10.html)
BE613108A (cg-RX-API-DMAC10.html)
BE613190A (cg-RX-API-DMAC10.html)
BE613298A (cg-RX-API-DMAC10.html)
BE613319A (cg-RX-API-DMAC10.html)